Chromis Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
Chromis General Information
Description
Producer of anti-flu drugs based in Russia. The company specializes in medicine for the treatment of viral diseases as well as against COVID-19.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
- Russia
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
- Russia
Chromis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Chromis Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Chromis FAQs
-
When was Chromis founded?
Chromis was founded in 2020.
-
Where is Chromis headquartered?
Chromis is headquartered in Russia.
-
What industry is Chromis in?
Chromis’s primary industry is Drug Discovery.
-
Is Chromis a private or public company?
Chromis is a Private company.
-
What is Chromis’s current revenue?
The current revenue for Chromis is .
-
Who are Chromis’s investors?
ChemRar High Tech Center and Russian Direct Investment Fund have invested in Chromis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process